This Danaos Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Wall Street analysts change outlook on top names. See all rating changes, upgrades, downgrades and initiations at Benzinga's analyst ratings page.
Read original at benzingaStocks · News reference
Sabra Sees FY26 Net Income Of $0.37-$0.39, FFO Of $1.12-$1.14, Normalized FFO Of $1.53-$1.55, AFFO Of $1.58-$1.60 And Normalized AFFO Of $1.59-$1.61
Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced a business update detailed below.Portfolio UpdateSabra has entered into letters of intent to re-tenant
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 21, 2026, 1:09 PM
- Checked
- Jul 21, 2026, 1:09 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Raymond James Upgrades Sabra Health Care REIT to Market Perform
Raymond James analyst David Rodgers upgrades Sabra Health Care REIT (NASDAQ:SBRA) from Underperform to Market Perform.
Read original at benzingaSabra Health Care REIT Lowers FY2026 FFO Guidance from $1.55-$1.59 to $1.53-$1.55 vs $1.55 Est
Sabra Health Care REIT (NASDAQ:SBRA) lowers FY2026 FFO guidance from $1.55-$1.59 to $1.53-$1.55 vs $1.55 analyst estimate..
Read original at benzingaSabra Health Care REIT Q2 FFO $0.39, Inline, Sales $235.866M Beat $219.689M Estimate
Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.39 per share which met the analyst consensus estimate. This is a 5.41 percent increase over earnings of $0.37 per share from the same period last
Read original at benzinga